Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 2
2019 1
2020 7
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Comprehensive GCMS and LC-MS/MS Metabolite Profiling of Chlorella vulgaris.
Pantami HA, Ahamad Bustamam MS, Lee SY, Ismail IS, Mohd Faudzi SM, Nakakuni M, Shaari K. Pantami HA, et al. Among authors: mohd faudzi sm. Mar Drugs. 2020 Jul 17;18(7):367. doi: 10.3390/md18070367. Mar Drugs. 2020. PMID: 32709006 Free PMC article.
A Review on Biological Properties and Synthetic Methodologies of the Diarylpentadienones.
Abdullah MA, Mohd Faudzi SM, Nasir NM. Abdullah MA, et al. Among authors: mohd faudzi sm. Mini Rev Med Chem. 2020 Dec 3. doi: 10.2174/1389557520999201203213957. Online ahead of print. Mini Rev Med Chem. 2020. PMID: 33272171
An Improved Nanoemulsion Formulation Containing Kojic Monooleate: Optimization, Characterization and In Vitro Studies.
Roselan MA, Ashari SE, Faujan NH, Mohd Faudzi SM, Mohamad R. Roselan MA, et al. Among authors: mohd faudzi sm. Molecules. 2020 Jun 4;25(11):2616. doi: 10.3390/molecules25112616. Molecules. 2020. PMID: 32512808 Free PMC article.
In silico studies, nitric oxide, and cholinesterases inhibition activities of pyrazole and pyrazoline analogs of diarylpentanoids.
Mohd Faudzi SM, Leong SW, Auwal FA, Abas F, Wai LK, Ahmad S, Tham CL, Shaari K, Lajis NH, Yamin BM. Mohd Faudzi SM, et al. Arch Pharm (Weinheim). 2021 Jan;354(1):e2000161. doi: 10.1002/ardp.202000161. Epub 2020 Sep 4. Arch Pharm (Weinheim). 2021. PMID: 32886410
Metabolite Profiles of Red and Yellow Watermelon (Citrullus lanatus) Cultivars Using a 1H-NMR Metabolomics Approach.
Sulaiman F, Ahmad Azam A, Ahamad Bustamam MS, Fakurazi S, Abas F, Lee YX, Ismail AA, Mohd Faudzi SM, Ismail IS. Sulaiman F, et al. Among authors: mohd faudzi sm. Molecules. 2020 Jul 15;25(14):3235. doi: 10.3390/molecules25143235. Molecules. 2020. PMID: 32679913 Free PMC article.
Inhibition of nitric oxide and prostaglandin E2 production by pyrrolylated-chalcones: Synthesis, biological activity, crystal structure analysis, and molecular docking studies.
Mohd Faudzi SM, Abdullah MA, Abdull Manap MR, Ismail AZ, Rullah K, Mohd Aluwi MFF, Mazila Ramli AN, Abas F, Lajis NH. Mohd Faudzi SM, et al. Bioorg Chem. 2020 Jan;94:103376. doi: 10.1016/j.bioorg.2019.103376. Epub 2019 Oct 24. Bioorg Chem. 2020. PMID: 31677861
Development of diarylpentadienone analogues as alpha-glucosidase inhibitor: Synthesis, in vitro biological and in vivo toxicity evaluations, and molecular docking analysis.
Abdullah MA, Lee YR, Mastuki SN, Leong SW, Wan Ibrahim WN, Mohammad Latif MA, Ramli ANM, Mohd Aluwi MFF, Mohd Faudzi SM, Kim CH. Abdullah MA, et al. Among authors: mohd faudzi sm. Bioorg Chem. 2020 Nov;104:104277. doi: 10.1016/j.bioorg.2020.104277. Epub 2020 Sep 14. Bioorg Chem. 2020. PMID: 32971414
Zebrafish phenotypic screen identifies novel Notch antagonists.
Velaithan V, Okuda KS, Ng MF, Samat N, Leong SW, Faudzi SM, Abas F, Shaari K, Cheong SC, Tan PJ, Patel V. Velaithan V, et al. Among authors: faudzi sm. Invest New Drugs. 2017 Apr;35(2):166-179. doi: 10.1007/s10637-016-0423-y. Epub 2017 Jan 5. Invest New Drugs. 2017. PMID: 28058624
Synthesis and sar study of diarylpentanoid analogues as new anti-inflammatory agents.
Leong SW, Faudzi SM, Abas F, Aluwi MF, Rullah K, Wai LK, Bahari MN, Ahmad S, Tham CL, Shaari K, Lajis NH. Leong SW, et al. Among authors: faudzi sm. Molecules. 2014 Oct 9;19(10):16058-81. doi: 10.3390/molecules191016058. Molecules. 2014. PMID: 25302700 Free PMC article.
Erratum to: Zebrafish phenotypic screen identifies novel Notch antagonists.
Velaithan V, Okuda KS, Ng MF, Samat N, Leong SW, Faudzi SM, Abas F, Shaari K, Cheong SC, Tan PJ, Patel V. Velaithan V, et al. Among authors: faudzi sm. Invest New Drugs. 2017 Apr;35(2):250. doi: 10.1007/s10637-017-0437-0. Invest New Drugs. 2017. PMID: 28185040 No abstract available.
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback